Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative

December 2017

Reps will promote Fiasp (FEE-asp, insulin aspart) as an "ultrafast-acting" mealtime insulin for adults.

Think of Fiasp as similar to NovoLog. They're both insulin aspart from the same company...except Fiasp has an additive to speed absorption.

Fiasp starts working about 5 minutes faster than NovoLog.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines Immunize Against Shingles With the New Vaccine, Shingrix
COPD Don't Jump to Spiriva First-Line for Mild COPD
NSAIDs Choose a Chronic NSAID Based on Safety
Acne Don't Use Oral Antibiotics Long-Term for Acne
Cardiology Look for Heart Failure Patients Who May Need an Aldosterone Antagonist
Insulin Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative
Constipation Emphasize an Effective Bowel Regimen for Opioid-Induced Constipation
Supplements Tell Diabetes Patients Not to Rely on Cinnamon
Gastroenterology Know When to Hold Meds Before Colonoscopy
Infectious Diseases Don't Consider Antibiotics for Most Patients With Acute Infectious Diarrhea